Results of Flavivirus Clinical Trial
Filed with ASX · · 4 pages · English
Watch Genetic Signatures' latest callGenetic Signatures (ASX:GSS) Q4 2026 Earnings Call · Replay · Aug 25Read the transcript of Genetic Signatures (ASX:GSS) Q4 2026 Earnings CallGenetic Signatures Ltd. on 6ix
Earlier from Genetic Signatures
- GSS Launches Sexually Transmitted Infection (STI) Kit
- Appendix 4D - Half Yearly Report and Accounts
- 2016 AGM MD and CEO Presentation
- STI Detection Kit Clinical Validation Trial Results
- Open Briefing - Capital Raising and Company Outlook
Later from Genetic Signatures
- Regulatory and Patent approval
- Appendix 4E and 2017 Financial Report
- 2017 AGM Presentation
- Appendix 4D and Half Year Financial Statements
- Positive Trial Results Presented at ECCMID
Follow Genetic Signatures into a list and get an email when it puts out news.
Follow Genetic Signatures